-
公开(公告)号：US20230256005A1
公开(公告)日：2023-08-17
申请号：US18092569
申请日：2023-01-03
发明人： Craig Sherman
CPC分类号： A61K33/00 , A61M1/1654
摘要： Provided herein are methods for maintaining physiological levels of nitrite in a subject undergoing hemodialysis. Also provided herein are methods of administering pharmaceutically acceptable sodium nitrite to a subject undergoing hemodialysis.
-
公开(公告)号：US20170129779A1
公开(公告)日：2017-05-11
申请号：US15409659
申请日：2017-01-19
CPC分类号： C01B17/64 , A61K9/0014 , A61K9/0019 , A61K31/404 , A61K31/4418 , A61K31/519 , A61K31/573 , A61K31/60 , A61K31/727 , A61K33/00 , A61K33/04 , A61K33/14 , A61K33/22 , A61K45/06 , C01P2006/80 , Y10T436/23
摘要： Provided herein are pharmaceutically acceptable sodium thiosulfate and pharmaceutical compositions thereof. Also provided herein are methods for determining the total non-purgeable organic carbon in a sodium thiosulfate-containing sample. Further provided herein are methods for producing pharmaceutically acceptable sodium thiosulfate. Still further provided herein are methods of treatment comprising the administration of pharmaceutically acceptable sodium thiosulfate.
-
公开(公告)号：US20130287676A1
公开(公告)日：2013-10-31
申请号：US13927241
申请日：2013-06-26
IPC分类号： C01B17/64
CPC分类号： C01B17/64 , A61K9/0014 , A61K9/0019 , A61K31/404 , A61K31/4418 , A61K31/519 , A61K31/573 , A61K31/60 , A61K31/727 , A61K33/00 , A61K33/04 , A61K33/14 , A61K33/22 , A61K45/06 , C01P2006/80 , Y10T436/23
摘要： Provided herein are pharmaceutically acceptable sodium thiosulfate and pharmaceutical compositions thereof. Also provided herein are methods for determining the total non-purgeable organic carbon in a sodium thiosulfate-containing sample. Further provided herein are methods for producing pharmaceutically acceptable sodium thiosulfate. Still further provided herein are methods of treatment comprising the administration of pharmaceutically acceptable sodium thiosulfate.
摘要翻译： 本文提供药学上可接受的硫代硫酸钠及其药物组合物。 本文还提供了用于测定含硫代硫酸钠的样品中的总不可清除的有机碳的方法。 本文还提供了用于生产药学上可接受的硫代硫酸钠的方法。 本文还提供了包括施用药学上可接受的硫代硫酸钠的治疗方法。
-
公开(公告)号：US20240285677A1
公开(公告)日：2024-08-29
申请号：US18658338
申请日：2024-05-08
发明人： Craig Sherman
CPC分类号： A61K33/00 , A61M1/1654
摘要： Provided herein are methods for maintaining physiological levels of nitrite in a subject undergoing hemodialysis. Also provided herein are methods of administering pharmaceutically acceptable sodium nitrite to a subject undergoing hemodialysis.
-
公开(公告)号：US20240277758A1
公开(公告)日：2024-08-22
申请号：US18397569
申请日：2023-12-27
发明人： Craig Sherman , Micah Bodner , Jon Marshall
IPC分类号： A61K33/04 , A61K9/00 , A61K31/717
CPC分类号： A61K33/04 , A61K9/0014 , A61K31/717
摘要： Provided herein are formulations comprising sodium thiosulfate. Also provided herein are methods of treating, preventing or ameliorating a sulfur mustard skin injury in a subject, wherein the methods comprise contacting the subject with a formulation provided herein.
-
公开(公告)号：US20240100086A1
公开(公告)日：2024-03-28
申请号：US18239405
申请日：2023-08-29
发明人： Craig Sherman
CPC分类号： A61K33/04 , A61M1/1654 , A61M1/1656
摘要： Provided herein are methods for maintaining physiological levels of thiosulfate in a subject undergoing hemodialysis. Also provided herein are methods of administering pharmaceutically acceptable sodium thiosulfate to a subject undergoing hemodialysis.
-
公开(公告)号：US20210100833A1
公开(公告)日：2021-04-08
申请号：US17126329
申请日：2020-12-18
发明人： Craig Sherman , Anthony James Lepine , Catherine Marie Smith , Kevin Robert Wirtz , Erich Schulze
IPC分类号： A61K33/00 , C01B21/50 , A61P17/00 , A61P9/00 , A61P43/00 , A61P11/00 , A61K31/17 , A61K31/4418 , A61K31/4709 , A61K31/519 , A61K9/08 , A61K9/00
摘要： Provided herein are pharmaceutically acceptable sodium nitrite and pharmaceutical compositions thereof. Also provided herein are methods for determining the total non-volatile organic carbon in a sodium nitrite-containing sample. Further provided herein are methods for producing pharmaceutically acceptable sodium nitrite. Still further provided herein are methods of treatment comprising the administration of pharmaceutically acceptable sodium nitrite.
-
公开(公告)号：US20200338120A1
公开(公告)日：2020-10-29
申请号：US16927901
申请日：2020-07-13
发明人： Craig Sherman
摘要： Provided herein are methods for maintaining physiological levels of thiosulfate in a subject undergoing hemodialysis. Also provided herein are methods of administering pharmaceutically acceptable sodium thiosulfate to a subject undergoing hemodialysis.
-
公开(公告)号：US20180256638A1
公开(公告)日：2018-09-13
申请号：US15973659
申请日：2018-05-08
发明人： Craig Sherman , Anthony James Lepine , Catherine Marie Smith , Kevin Robert Wirtz , Erich Schulze
IPC分类号： A61K33/00 , A61K31/4709 , A61K9/08 , A61K31/519 , A61K31/4418 , A61K31/17 , C01B21/50 , A61K9/00
摘要： Provided herein are pharmaceutically acceptable sodium nitrite and pharmaceutical compositions thereof. Also provided herein are methods for determining the total non-volatile organic carbon in a sodium nitrite-containing sample. Further provided herein are methods for producing pharmaceutically acceptable sodium nitrite. Still further provided herein are methods of treatment comprising the administration of pharmaceutically acceptable sodium nitrite.
-
公开(公告)号：US20220063999A1
公开(公告)日：2022-03-03
申请号：US17469006
申请日：2021-09-08
IPC分类号： C01B17/64 , A61K33/14 , A61K33/22 , A61K33/04 , A61K31/404 , A61K31/519 , A61K31/573 , A61K31/60 , A61K45/06 , A61K33/00 , A61K9/00 , A61K31/4418 , A61K31/727
摘要： Provided herein are pharmaceutically acceptable sodium thiosulfate and pharmaceutical compositions thereof. Also provided herein are methods for determining the total non-purgeable organic carbon in a sodium thiosulfate-containing sample. Further provided herein are methods for producing pharmaceutically acceptable sodium thiosulfate. Still further provided herein are methods of treatment comprising the administration of pharmaceutically acceptable sodium thiosulfate.
-
-
-
-
-
-
-
-
-
搜索结果
34 条记录 (耗时 0.02 秒)
